Two cases of lung granulomata associated with 'crescentic' glomerulonephritis both in a clinical setting of polyarteritis nodosa were treated with high doses of intravenous methylprednisolone ('pulse therapy') in single injections of 30 mg/kg body-weight. In the first case rapidly progressive glomerulonephritis with 100% crescents was arrested and followed by improvement of renal function from a creatinine clearance of 5 ml/min to 30 ml/min; in the second case multiple lung granulomata of 8 months' standing, unresponsive to oral steroids, disappeared 8 days after treatment with high dosage intravenous methylprednisolone.
Introduction
The treatment of polyarteritis nodosa (PAN) with high dose oral corticosteroids is not always successful and frequently complicated by the high attendant morbidity of the steroids. Moreover rapidly progressive glomerulonephritis (a clinico-pathological entity characterized by a rapid deterioration in renal function in days or weeks and histologically by extensive epithelial cell proliferation forming crescents that occlude Bowman's space) has, whatever the cause, almost always a fatal outcome. When this is associated with polyarteritis nodosa the outcome untreated is always fatal (Harrison, Loughridge and Milne, 1964) .
Impressed by the lack of toxicity of high doses of intravenous methylprednisolone (30 mg/kg bodyCorrespondence: Professor H. A. Lee, Department of Nephrology, University of Southampton and Wessex Regional Renal Unit, Portsmouth P03 6AD. weight) in renal transplantation work and the reduction in steroid-associated morbidity that they have seen in the past 4 years at the Wessex Regional Renal Unit, the authors treated a patient with rapidly progressive glomerulonephritis associated with a lung granuloma in whom the clinical diagnosis was polyarteritis nodosa. This recovery was so impressive that they were encouraged to use similar treatment in a patient with clinical polyarteritis nodosa and multiple recurrent lung granulomata in whom severe steroid morbidity, particularly multiple vertebral collapse discouraged any further increase in his oral dosage of steroids. Again the rapidity of sustained improvement was very impressive. The two cases are described and the implications discussed.
Case 1
A 59-year-old man working on a refrigerator assembly line had been perfectly well until 5 weeks before hospital admission, when he had an influenzalike illness, which never completely cleared. Sixteen days before admission he had an acute arthritis of the right ankle. This soon settled with analgesics but was followed by malaise, pyrexia and myalgia in the neck and shoulders. He was given amoxycillin. He developed painful mouth ulcers and 5 days before admission a left foot drop.
On examination, he had a petechial rash over his arms and lower legs and small vasculitic lesions around his nail beds and finger tips, associated with pinhead size areas of skin necrosis. A chest X-ray showed a mass in his right upper lobe. His haemoglobin was 10-7 g/dl, WBC 27 x 109/l (27% eosinophilia), ESR 80 mm/hr and blood urea 10-5 mmol/l. He A diagnosis of very severe rapidly progressive glomerulonephritis with 100% crescents, a solitary lung granuloma, in a clinical setting of polyarteritis nodosa was made although histologically no arteritis was demonstrated.
He was treated with intravenous 'pulses' of methylprednisolone 1500mg (30 mg/kg body-weight), four times at 48-hr intervals. He was also put on a 'background' dose of prednisolone 20 mg/day.
There was no further decline in his renal function. His serum creatinine fell very slowly to 05 mmol/l and his urine output remained at 1-2 I/day. A salt depletion episode complicated his recovery.
With salt repletion his creatinine fell rapidly to 0-2 mmol/l and the creatinine clearance rose to 20 ml/min. After 4 weeks he was re-biopsied. Repeat biopsy showed twenty-one of the twenty-five glomeruli to be obsolescent, three glomeruli appeared almost uninvolved showing only minimal mesangioproliferation (Fig. 2) . There was very severe tubular atrophy and diffuse interstitial fibrosis. (Fig. 3) . In view of the previous steroid-induced complications it was decided to treat him with intravenous 'pulses' of methylprednisolone every other day for four doses. Within 8 days of starting, the granulomata had disappeared (Fig. 4) . However, owing to his severe immobility he did not otherwise improve and, despite enthusiastic attempts at mobilization, his severe back pain became incapacitating and he died in June.
Discussion
Before the introduction of steroids, polyarteritis nodosa (PAN) was ultimately fatal in most cases, although death was sometimes not due to active arteritis but to the sequelae of lesions where active disease had ceased (M.R.C. Report, 1957) . Steroids have been shown to modify the course and improve the symptoms of PAN although not improving overall survival time: although one year survival figures are much improved by steroids, at 3 years there is no advantage (M.R.C. Report, 1960; Frohnert and Sheps, 1967) . However, in PAN and other collagen diseases, to suppress disease activity very large maintenance doses of steroids may need to be given and the attendant morbidity may become more serious or disabling than the disease itself. Among the complications are osteoporosis leading to vertebral collapse with pain and neurological complications, diabetes mellitus, myopathy, cosmetic problems, cataracts and haemorrhage from peptic ulceration.
Very high doses of intravenous steroids ('pulses', 30 mg/kg body-weight) have been used for several years to reverse organ transplant rejection and their efficacy has been proved (Bell et al., 1971; Feduska et al., 1972) .
Recently Cathcart et al. (1976) , have described the use of intravenous 'pulses' of high doses of methylprednisolone in diffuse proliferative lupus nephritis with rapid deterioration of renal function. They were initially impressed by the histological appearances in a renal biopsy of one such patient and its similarities with acute renal transplant rejection. In all five cases there was a rapid improvement in renal function with a return to baseline creatinine levels in 1 month.
This group of patients would be treated in some other units with a mixture of steroids, azathioprine, dipyridamole and anti-coagulants as popularized by Kincaid-Smith's unit in Melbourne (Kincaid-Smith, Saker and Fairley, 1968; Brown et al., 1974) .
The use of steroids in PAN and in other collagen diseases is empirical. The mechanism of action is unknown as are the aetiologies and pathogeneses of the diseases they are used in. By analogy with vascular lesions seen in animal experimental models of acute serum sickness (Dixon et al., 1958) , PAN is thought to be a soluble immune complex disease in which complexes are deposited in vessel walls initiating inflammatory responses, which are neutrophil mediated and resulting in arteritic lesions. Arteritic lesions are found in other 'soluble complex diseases' such as systemic lupus erythematosus and rheumatoid arthritis (Sokoloft, 1963) , cryoglobulinaemia (Case Records, 1974) , post-streptococcal nephritis (Fordham et al., 1964 ) and Wegener's granulomatosis (Howell and Epstein, 1976) . In PAN Australia antigen-antibody (Ag-Ab) complexes have occasionally been found in the blood and incriminated in the pathogenesis of the arteritis (Gocke et al., 1970) , but never has the complex actually been identified in the arteritic lesion.
In these diseases steroids act to suppress tissue inflammation and possibly to inhibit the formation of soluble Ag-Ab complexes, either by dissociation of the complexes or by alteration of the quality or quantity of the antibodies or antigens. Although the mechanisms of action of steroids are unknown, high doses of intravenous methylprednisolone have been shown to inhibit neutrophil accumulation in injured tissue (Weiner et al., 1975) .
High oral doses of prednisolone have been shown to be lympholytic resulting in T and to a lesser degree B cell lymphopenia (Yu et al., 1974) . Short courses of high oral doses of methylprednisolone produce a fall in serum IgG levels by an increase in catabolism during the drug administration and a decrease in IgG synthesis, both during administration and for a variable time afterwards (Butler and Rossen, 1973) .
Both these cases had lung granulomata associated with crescentic glomerulonephritis as part of a multi-system disorder typical of polyarteritis nodosa, although no arteritic lesions were seen in either of the renal biopsies.
In case 2 lung granulomata disappeared most dramatically in 8 days after intravenous methylprednisolone whereas previously they had taken 6-8 months to disappear on high doses of oral prednisolone. In case 1 rapidly progressive renal failure was arrested and then gradually improved from a creatinine clearance of 5*0 ml/min to 30 ml/min, although, residual renal damage, as judged by a second biopsy was severe. The solitary apical lung granuloma disappeared in 2 weeks and after 1 month he was well and at home.
Although the use of steroids remains empirical in any dose, its efficacy has been shown. It 
